Lexaria Awarded New PatentsAccesswire • about 1 month ago
Lexaria receives new patents in the fields of epilepsy and anti-viral agentsKELOWNA, BC / ACCESSWIRE / April 2, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the 'Company' or...
Share to Feed
Kelowna, British Columbia--(Newsfile Corp. - March 21, 2024) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
KELOWNA, BC / ACCESSWIRE / March 14, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms announces the appointment...
Lexaria Bioscience files to sell 1.61M shares of common stock for holders...
Lexaria Bioscience Corp. (LEXX) has released an update. Lexaria Bioscience Corp. has embarked on its second human pilot study using its proprietary...
First-ever dissolvable DehydraTECH-GLP-1 oral dose formulation to be testedRybelsus(R) semaglutide will act as the positive controlKELOWNA, BC / ACCESSWIRE / March 7, 2024 / Lexaria Bioscience Corp...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be testedChronic dosing over a 12-week treatment periodWill assess weight loss and blood glucose level controlEfficacy through possible...
KELOWNA, BC / ACCESSWIRE / March 4, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, informs that its...